Occidental Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-10,435
| Closed | -$74K | – | 155 |
|
2020
Q1 | $74K | Sell |
10,435
-3,550
| -25% | -$25.2K | 0.04% | 136 |
|
2019
Q4 | $334K | Sell |
13,985
-665
| -5% | -$15.9K | 0.14% | 126 |
|
2019
Q3 | $393K | Sell |
14,650
-233
| -2% | -$6.25K | 0.16% | 116 |
|
2019
Q2 | $404K | Buy |
14,883
+83
| +0.6% | +$2.25K | 0.18% | 114 |
|
2019
Q1 | $514K | Buy |
14,800
+1,400
| +10% | +$48.6K | 0.25% | 86 |
|
2018
Q4 | $262K | Sell |
13,400
-700
| -5% | -$13.7K | 0.15% | 117 |
|
2018
Q3 | $375K | Buy |
14,100
+140
| +1% | +$3.72K | 0.19% | 108 |
|
2018
Q2 | $527K | Buy |
13,960
+700
| +5% | +$26.4K | 0.28% | 67 |
|
2018
Q1 | $433K | Buy |
13,260
+750
| +6% | +$24.5K | 0.23% | 76 |
|
2017
Q4 | $609K | Sell |
12,510
-600
| -5% | -$29.2K | 0.32% | 54 |
|
2017
Q3 | $708K | Buy |
13,110
+1,110
| +9% | +$59.9K | 0.39% | 48 |
|
2017
Q2 | $674K | Buy |
12,000
+650
| +6% | +$36.5K | 0.4% | 44 |
|
2017
Q1 | $445K | Hold |
11,350
| – | – | 0.29% | 55 |
|
2016
Q4 | $255K | Sell |
11,350
-250
| -2% | -$5.62K | 0.18% | 98 |
|
2016
Q3 | $263K | Hold |
11,600
| – | – | 0.21% | 80 |
|
2016
Q2 | $274K | Buy |
+11,600
| New | +$274K | 0.24% | 74 |
|